Address And Details

32 Old Slip , New York, NY 10005
Fund Manager Basak Yavuz
Manager Tenure 6 Years 7 Months

Strategy And Objective

The Goldman Sachs Emerging Markets Equity Fund (the Fund ) seeks long-term capital appreciation. The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) ( Net Assets ) in a diversified portfolio of equity investments in emerging country issuers. Such equity investments may include exchange-traded funds ( ETFs ), futures and other instruments with similar economic exposures. The Investment Adviser may consider classifications by the World Bank, the International Finance Corporation, the United Nations (and its agencies) or the Fund s benchmark index provider in determining whether a country is emerging or developed. Emerging countries are generally located in Africa, Asia, the Middle East, Central and Eastern Europe and Central and South America. Under normal circumstances, the Fund maintains investments in at least six emerging countries. Allocation of the Fund s investments is determined by the Investment Adviser s assessment of a company s upside potential and downside risk, how attractive it appears relative to other holdings, and how the addition will impact sector and industry weightings. The largest weightings in the Fund s portfolio relative to the benchmark of the Fund are given to companies the Investment Adviser believes have the most upside return potential relative to their contribution to overall portfolio risk. The Fund s investments are selected using a strong valuation discipline to purchase what the Investment Adviser believes are well-positioned, cash-generating businesses run by shareholder-oriented management teams. The Fund may invest in the aggregate up to 20% of its Net Assets in: (i) fixed income securities of private and government emerging country issuers; and (ii) equity and fixed income securities, such as government, corporate and bank debt obligations, of developed country issuers. The Fund s benchmark index is the Morgan Stanley Capital International (MSCI) Emerging Markets Index (Net, USD, Unhedged).

Net Asset Value

as of 6:01 PM ET 09/22/2021

Performance

  • 1 Week
  • -2.07%
  • 1 Month
  • +2.41%
  • 3 Months
  • -3.12%
  • 1 Yr Return
  • +25.12%
  • 5 Yr Return
  • +74.79%

Equity Sector Breakdown

Technology 22.39%
RetailTrade 18.82%
Finance 18.45%
IndustrialCyclical 6.80%
NonDurables 6.57%
Services 3.09%
Health 2.84%
ConsumerDurables 2.08%
Utilities 1.73%
Energy 0.52%

Asset Allocation

Asset Type % Of Allocation
Stocks 96.71%
ForeignStocks 94.70%
Other 3.36%
Preferred 0.54%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 285.79 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.22 0.02 -6.60
Beta 0.83 0.80 0.94
R Squared 0.60 0.49 0.52
Std Deviation 19.73 17.16 17.34
Sharpe Ratio 0.85 0.83 n/a

Purchase Information

as of 6:00 PM ET 09/21/2021
Minimum Initial $1000
Minimum Additional $50
Minimum Initial IRA $250

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +27.09%
  • +47.07%
+27.09% +47.07%
3 Year
  • +15.72%
  • +16.01%
+15.72% +16.01%
10 Year
  • +7.01%
  • +6.38%
+7.01% +6.38%
Life Of Fund
  • +7.48%
  • +7.68%
+7.48% +7.68%

Top 10 Holdings

Symbol Company Name % Of Assets
TSM TAIWAN SEMICONDUCTOR MANUFACT 7.00%
067166 SAMSUNG ELECTRONICS CO LTD 6.90%
0700.HK TENCENT HOLDINGS LTD 6.46%
BABA.N ALIBABA GROUP HOLDING LTD 6.11%
600036.S CHINA MERCHANTS BANK COMPANY 2.33%
ESGE ISHARES ESG AWARE MSCI EM 2.06%
3690 MEITUAN CLASS B 2.05%
600519.S KWEICHOW MOUTAI CO LTD 2.01%
601318.S PING AN INSURANCE GROUP 1.87%
MELI MERCADOLIBRE INC 1.49%

Recent Articles from TheStreet

Novavax Lead

Novavax Stock Surges on Covid-19 Vaccine Application to WHO

Novavax and Serum Institute of India have applied to the WHO for an emergency use listing of Novavax's Covid-19 vaccine.

Why It's Unhealthy to Own Rite Aid, Plus Jim Cramer's Take

Rite Aid Stock Must Hold This Key Support Level After Dip on Earnings

Rite Aid stock has one key support level left before more potential downside. Investors trading the stock should keep that level in mind.

Cannabis Weed Marijuana Federal Lead

U.S. Cannabis Stocks Rise on Effort to Allow Bank Financing

Measure to allow banks to finance the cannabis industry passes voice vote in U.S. House.

Wall Street Lead

Dow Climbs On Fed Tapering Stance; Evergrande Debt In Focus

Stocks surge amid the Fed's patience on tapering and amid cautious optimism for a brokered solution to the Evergrande debt crisis.

Joby Aviation Lead

Air Taxi Maker Joby Aviation Rated Overweight by Morgan Stanley

Joby is 'a first mover to address the urban air mobility market,' which Morgan Stanley sees at $1 trillion in 2040 and $9 trillion in 2050.

Get Excited About Roku: Streaming Content Is Starting to Get Very Interesting

Roku Lifted to Buy; Guggenheim Sees Growth Overseas, Ad Potential

Guggenheim raised Roku to a buy based on the streaming-tech company's growth potential overseas and more potent advertising capabilities.

Nouriel Roubini Lead

Roubini Sees Overheated Growth, Then Rampant Stagflation

'The rosy scenario that is currently priced into financial markets may turn out to be a pipe dream,' says the famously bearish economist Nouriel Roubini.